Cardiogenic shock patients with severe mitral regurgitation (MR) are among the most critically ill receiving care at the University of Ottawa Heart Institute (UOHI). Most frequently occurring in patients who have suffered a severe heart attack, those with cardiogenic shock have difficulty pumping...
Search
Displaying 1 - 20 of 198
Common practice during complex arrhythmia ablation procedures, such as atrial fibrillation and ventricular tachycardia ablation, calls for the use of radiation to help visualize catheter movement and guide the electrophysiologist through critical portions of the procedure. This type of radiation...
Responsible for countless health problems, including cardiovascular and respiratory illness, and many forms of cancer, smoking commonly leads to hospitalization. Surprisingly, a minority of Canadian hospitals have systems, policies or procedures in place that support the consistent, effective...
All of us have experienced anxiety, sadness, frustration or other negative emotions. While they can cause mental distress, they can also take a toll on your heart health, especially if these feelings are persistent or frequent. Understanding and dealing with our moods is important for both...
A heart attack is never good, but a STEMI heart attack is the most serious and deadly. It means that one of the arteries that deliver blood to the heart is completely blocked. The longer the heart goes without blood, the greater the damage. In 2004, the Ottawa Heart Institute launched its STEMI...
To take the sick or damaged heart out of a person’s body and replace it with a healthy donor heart, often flown in from far away—the very idea of a heart transplant inspires wonder. In May 1984, Wilbert Keon, MD, founder of the University of Ottawa Heart Institute, performed the first-ever heart...
Roughly half a million Canadians live with heart failure. The condition is an increasingly common one that can seriously impact an individual’s quality of life. Even when appropriately treated, hospital admission and readmission rates are stubbornly high. Traditionally, therapeutic implants called...
In 2012, the promise of using genetic information to personalize patient care made a leap forward at the Ottawa Heart Institute, with the introduction of the RAPID GENE test. Patients who get a cardiac stent to open a blocked artery must take medication to prevent blood clots. Clopidogrel is most...
If they weren’t such a modest lot—and if they hadn’t been quite so tired—you might have heard the sounds of celebration at the University of Ottawa Heart Institute last month. It was an occasion truly worth celebrating—the Heart Institute’s 500th heart transplant since the program began in 1984. At...
A dedicated staff committed to education. A referral base of 2 million people that offers an amazing range of clinical conditions that enable learning. A vigorous, wide-ranging research program. A supportive administration that believes in continual improvement. The full breadth of clinical care...
Researcher Thomas Lagace, PhD, first came across the protein PCSK9 as a postdoctoral fellow, never guessing that it would become the focus of his career. While starting his post-doc at University of Texas Southwestern Medical Center, he was placed “kind of kicking and screaming,” as he put it, on a...
Participants at the University of Ottawa Heart Institute’s 25th Annual Research Day attend a research presentation. The program included more than 75 presentations in the categories of basic science, clinical science, and allied and population health. May 7, 2012, marked the 25th Annual Research Day...
In December 2010, McGraw Hill publishers released the 13th edition of Hurst’s The Heart, one of the essential texts in cardiovascular medicine for more than 40 years. This edition marks a major revision, with 19 new chapters and 59 new authors. Dr. Robert Roberts, President and CEO of the University...
Family medicine is an important setting for managing cardiovascular risk factors and preventing the onset of heart disease, as well as managing risk factors following a cardiac event. If a patient is a smoker, explained Dr. Andrew Pipe, Chief of Prevention and Rehabilitation at the University of...
Following Burgon’s talk at the International Forum, Philip Devereaux of McMaster University spoke about Canada’s unique place in the world of cardiovascular medicine. Not only is cardiovascular disease (CVD) the leading cause of death globally but by 2020, the incidence in developing countries is...
Dr. Ruth McPherson, an active CARDIoGRAM participant and a co-author on the interferon biomarker study, was honoured by the AHA Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) with its Special Recognition Award. Dr. McPherson, a tireless clinician and scientist, directs the...
The State of the Science Lecture on Women and Heart Disease by Anne Rosenfeld of the Oregon Health Sciences University made it clear that there is much to learn about the ways the disease is unique to women. What we do know indicates that risk, symptoms, progression and treatment of CVD are all...
Research from around the world was presented at the 2014 American Heart Association (AHA) Scientific Sessions in November. The following highlights range from large drug trials to new information about the causes and of heart disease and the value of good heart health. Preventing Clots Following...
More than 32,000 Canadians go into cardiac arrest each year outside of a hospital and more than 90 per cent of them die. In many cases, this is because bystanders didn’t have adequate knowledge of CPR or access to an automated external defibrillator (AED). Guidelines and studies presented at the...
Although most cases of high blood pressure have no easily identifiable cause, the condition’s effects are clear, including increased risk of stroke, heart attack, and heart failure. The medical consensus is that using medications to lower blood pressure benefits patients, but how low has remained an...